High Tech Pharm Co Ltd. manufactures sterile and oral antibiotics.  The Company's products include sterile bulk forms of Cephalosporine and Carbapenem related antibiotics.  High Tech Pharm also exports active pharmaceutical ingredients.

Outcomes of Annual Meeting of Shareholders

Submission of Audit Report

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

High Tech Pharm (106190 KS)

Outcomes of Annual Meeting of Shareholders

Submission of Audit Report

Resolutions for Convocation of General Meeting of Shareholders

Reporting reasons for holding general shareholders' meeting on the most concentrated date

30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)